Search Results
Article
Acceptability of long-acting injectable cabotegravir (CAB LA) in HIV-uninfected individuals: HPTN 077
February 12, 2020
Article
Methods for generalized change-point models: With applications to human immunodeficiency virus surveillance and diabetes data
April 15, 2020
Chapter
Randomized clinical trials
September 23, 2020
Article
Cabotegravir is not associated with weight gain in human immunodeficiency virus-uninfected individuals in HPTN 077
January 15, 2020